LUPIN

💊 Lupin Ltd — Company Overview

✅ Why One Might Consider Investing in Lupin Diverse business model with global reach Lupin covers multiple nodes of the pharma value chain — just manufacturing generics isn’t the full story. With APIs, formulations, speciality and branded businesses, the company is not dependent on a single geography or business type. That gives it structural resilience. Strong presence in key therapeutic segments The company has significant capabilities in areas such as anti-tuberculosis, cardiovascular, respiratory, diabetology, CNS and women’s health. These are areas with stable and secular demand. Improving U.S. and export business momentum Export markets, especially the U.S., offer scale, margin expansion and growth upside. For a company like Lupin, execution in these markets is a key lever for future earnings. Capacity & R&D investments With multiple manufacturing sites, research centres and a global footprint, Lupin is investing for the future — which is important in pharma where regulatory, product approval, patent cliffs and manufacturing quality all matter. Relatively undervalued potential & structural tailwinds Compared to the size of the opportunity (global generics, speciality drugs, emerging markets), there might be upside potential if things go right. For an investor with a medium- to long-term horizon, Lupin offers a path to participate in the global pharma story from an Indian base.